Aktieanalys

Iconovo: Progress in intranasal GLP-1 development - Redeye

{newsItem.title}

Redeye Publicerad: 11 Jun 13:48

Redeye is positive about Iconovo’s progress in the GLP-1 space and notes that the development timeline appears to be on track. We look forward to upcoming updates and will continue to closely follow the programme as it advances.

Länk till analysen i sin helhet: https://www.redeye.se/research/1115149/iconovo-progress-in-intranasal-glp-1-development?utm_source=finwire&utm_medium=RSS

Nyheter om Iconovo

Läses av andra just nu

Om aktien Iconovo

Senaste nytt